J L Anderson Selected Research

J L Anderson Research Topics

Disease

8	Coronary Artery Disease (Coronary Atherosclerosis) 02/2001 - 01/2000
6	Body Weight (Weight, Body) 10/2018 - 08/2015
4	Inflammation (Inflammations) 03/2005 - 06/2000
3	Multiple Myeloma 12/2016 - 04/2001
3	Infections 03/2005 - 06/2000
3	Pathologic Constriction (Stenosis) 02/2001 - 10/2000
2	Neoplasms (Cancer) 12/2016 - 04/2001
2	Atherosclerosis 07/2008 - 03/2005
1	Neoplasm Metastasis (Metastasis) 12/2016
1	Hypoxia (Hypoxemia) 12/2016
1	Heart Failure 06/2016
1	Atherosclerotic Plaque (Atheroma) 06/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2012
1	Hemorrhage 10/2012
1	Venous Thromboembolism 10/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2012
1	Muscular Dystrophies (Muscular Dystrophy) 04/2005
1	Coronary Disease (Coronary Heart Disease) 03/2005
1	Heart Diseases (Heart Disease) 11/2001
1	Ventricular Tachycardia 11/2001
1	Ventricular Fibrillation 11/2001
1	Hypertrophy 10/2001
1	familial dilated cardiomyopathy 10/2001
1	Bone Diseases (Bone Disease) 04/2001
1	Sepsis (Septicemia) 01/2001
1	Myocardial Infarction 11/2000
1	Heart Arrest (Cardiac Arrest) 10/2000
1	Unstable Angina 10/2000
1	Stroke (Strokes) 10/2000

Drug/Important Bio-Agent (IBA)

4	Azithromycin (Zithromax)FDA LinkGeneric 03/2005 - 06/2000
3	Verapamil (Calan)FDA LinkGeneric 05/2017 - 08/2016
3	CholesterolIBA 06/2014 - 11/2000
3	C-Reactive ProteinIBA 11/2000 - 09/2000
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 07/2008
2	LipidsIBA 02/2001 - 11/2000
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2001 - 11/2000
1	NitrogenIBA 10/2018
1	Glucose (Dextrose)FDA LinkGeneric 10/2018
1	Urea (Carbamide)FDA LinkGeneric 10/2018
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 12/2016
1	Galectin 1 (LGALS1)IBA 12/2016
1	Progesterone FDA LinkGeneric 08/2015
1	activin AIBA 04/2014
1	Interleukin-3 (Interleukin 3)IBA 04/2014
1	Warfarin (Coumadin)FDA LinkGeneric 10/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 07/2008
1	GelsIBA 07/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2008
1	Fatty Acid-Binding ProteinsIBA 07/2008
1	ribophorinIBA 07/2008
1	Myosin-Light-Chain PhosphataseIBA 07/2008
1	Laminin (Merosin)IBA 04/2005
1	Pravastatin (Pravachol)FDA LinkGeneric 03/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2005
1	Gatifloxacin (Zymar)FDA Link 03/2005
1	Atorvastatin (Lipitor)FDA Link 03/2005
1	Troponin T (Troponin T1)IBA 10/2001
1	Ibandronic Acid (Boniva)FDA Link 04/2001
1	Diphosphonates (Bisphosphonates)IBA 04/2001
1	Adenosine Triphosphate (ATP)IBA 01/2001
1	3-aminobenzamideIBA 01/2001
1	pimagedine (aminoguanidine)IBA 01/2001
1	LipopolysaccharidesIBA 01/2001
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2001
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2001
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2000
1	HDL LipoproteinsIBA 11/2000
1	oxidized low density lipoproteinIBA 11/2000
1	Immunoglobulin G (IgG)IBA 10/2000
1	CytokinesIBA 10/2000
1	HomocysteineIBA 09/2000
1	E-SelectinIBA 01/2000
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2000
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2000

Therapy/Procedure

6	Therapeutics 03/2005 - 10/2000
2	Secondary Prevention 03/2005 - 10/2000
1	Catheters 04/2018
1	Length of Stay 06/2016
1	Operative Surgical Procedures 10/2012
1	Transplantation 09/2012
1	Subcutaneous Injections 04/2001